LISATA THERAPEUTICS, INC. Stock Split Ratio
LISATA THERAPEUTICS, INC. (LSTA) had Stock Split Ratio of 53.38% as of 2022-09-15, per its 10-K filed 2023-03-30.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-30
- 2022-09-15: Stockholders' Equity Note, Stock Split, Conversion Ratio 53.38%.
- 2022-09-14: Stockholders' Equity Note, Stock Split, Conversion Ratio 1500.00%.
- 2016-07-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2022-09-15 | 53.38% 10-K · filed 2023-03-30 |
| 2022-09-14 | 1500.00% 10-K · filed 2023-03-30 |
| 2016-07-28 | 10.00% 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |